Pay in 4 interest-free payments of $6.13 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Compound: Retatrutide Format: Lyophilized peptide research vial Available Strengths: 10MG, 20MG, and 30MG Research Category: GLP-1 / GIP / glucagon triple agonist peptide research Research Focus: Incretin biology, metabolic regulation, GLP-1 receptor pathway research, GIP receptor signaling, glucagon receptor models, substrate utilization, energy-balance biology, and appetite-associated pathway research
When you activate multiple receptors that are expressed in different tissues or even on the same cells you dont just add effects
Tirzepatide (Mounjaro, Zepbound) is a dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist, representing a distinct but related medication class
however, compounded drugs lack the same level of safety, quality and efficacy assurances as approved drugs
Vartak D, Gemeinhart RA: Matrix metalloproteases: underutilized targets for drug delivery
Ozempic isnt the only drug that mimics the natural GLP-1 hormone, so users feel fuller for longer and eat less
US$ 20.43
US$ 20.28
US$ 20.37
US$ 23.44
US$ 20.87
